Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UVA Devices was a medical technology company that specialized in the development and manufacture of high-output UVA-1 phototherapy systems for treating severe dermatological and systemic conditions. Spun out from the University of Virginia, the company addressed a critical gap in the U.S. market by providing specialized equipment capable of delivering long-wave ultraviolet radiation, which penetrates deeper into the skin than traditional UVB therapy. Their flagship product was designed to treat conditions such as scleroderma, morphea, and atopic dermatitis, which are often refractory to conventional treatments. By offering high-performance, clinical-grade devices, UVA Devices aimed to improve patient access to advanced phototherapy options in a clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UVA Devices.